Abstract

Azstarys in Ora-Blend Single Dose

Author(s): Allen Loyd V Jr

Issue: May/Jun 2022 - Volume 26, Number 3

Page(s): 233

Download in electronic PDF format for $75

Note: Electronic version includes supplemental material.

Abstract

A formulation for preparing Azstarys in Ora-Blend Single Dose. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
May/Jun 2022 Pg. 233	Azstarys in Ora-Blend Single Dose Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 87-89	Attention Deficit Hyperactivity Disorder Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 21-22	Methylphenidate in the Treatment of Attention Deficit Disorders Author(s): Tenreiro Kim
Nov/Dec 2014 Pg. 496	Dexmethylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2003 Pg. 441-447	Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care Author(s): Fassett William E
Jan/Feb 2001 Pg. 6-8	Pediatric Compounding: Coloring Outside the Lines Author(s): Preckshot John
Nov/Dec 2023 Pg. 468-473	Case Study: Personalized Oral Low-dose Naltrexone Titration for Pain Management Author(s): Rodriguez Franklin, Carvalho Maria, Banov Fabiana
Mar/Apr 2010 Pg. 171-173	Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders Author(s): Ploesser Jennifer, Weinstock Leonard B, Thomas Erin
Sep/Oct 2021 Pg. 414	Clonidine 0.01-mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 501	Methylphenidate Hydrochloride 10-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 239-246	Topical Metered-dosing Dispenser Performance Evaluation Author(s): Liu Qiang, Kupiec Thomas C, Vu Nicole T
Jan/Feb 2018 Pg. 41-46	Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy Author(s): Kosinski Tracy M, Brown Michael C, Zavala Pedro J
Jul/Aug 2018 Pg. 270-278	Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Author(s): Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
Jul/Aug 2018 Pg. 268	PreScription: Factors Related to Drug Waste and Pharmacy Solutions Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 496	Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 32-38	Unit Dose Packaging and Repackaging of Solid and Liquid Dosage Forms in an Institutional Setting Author(s): McElhiney Linda F
Nov/Dec 2021 Pg. 506	Quetiapine Fumarate 10 mg/mL in Ora-Blend Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 358-366	Current Trends and Emerging Priorities in Compounded Preparations for Children Author(s): Parrish Richard H II
Mar/Apr 2020 Pg. 94-96	Low-dose Naltrexone Therapy for Psoriasis Author(s): Weinstock Leonard B, Cottel Jill, Aldridge Lindsey, Egeberg Alexander
Jul/Aug 2020 Pg. 346-351	Single Center Experience with Robot Technologies for Sterile Compounding: A Retrospective Review Author(s): Milibari Loay, Cotugno Michael, Belisle Caryn, Rocchio Megan, Patterson Robert F, Chacon Pablo, Fanikos John, Vo Peter